Clinical Trial Update: Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ABT-414 in Japanese subjects with malignant glioma (phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• ABT-414 (depatuxizumab mafodotin)

Snippet

Sponsor: AbbVie | Conditions: Malignant Glioma, Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED